Diaminocyclopentyl substituted heteroaryl derivatives, use thereof and preparation method therefor
Patent Information
- Application Number
- HK62026126307
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-14
- Filing Date
- 2026-07-17
- Publication Date
- 2026-09-11
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480040806.5 (22) Application Date 2024.07.26 (66) Domestic Priority Data 202310930420.9 2023.07.27 CN 202311791758.7 2023.12.25 CN 202410707101.6 2024.06.03 CN 202410766231.7 2024.06.14 CN (85) PCT International Application Entering National Phase Date 2025.12.18 (86) PCT International Application Application Data PCT / CN2024 / 107781 2024.07.26 (87) Publication data of PCT international application WO2025 / 021188 ZH 2025.01.30 (71) Applicant Shanghai Tuojie Biomedical Technology Co., Ltd. Address Room 103, Building 14, No. 3728 Jinke Road, Pudong New Area, Shanghai 201203 (72) Inventors Hu Tao Tan Liang Liu Haomiao Li Yunfei (74) Patent Agency Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney Cheng Wei (51) Int.Cl. C07D 491 / 056 (2006.01) C07D 471 / 04 (2006.01) C07D 498 / 04 (2006.01) C07D 401 / 02 (2006.01) C07D 417 / 12 (2006.01) C07D 487 / 04(2006.01) C07D 401 / 12(2006.01) C07D 403 / 12(2006.01) A61K 31 / 519(2006.01) A61K 31 / 444(2006.01) A61K 31 / 501(2006.01) A61K 31 / 505(2006.01) A61K 31 / 4745(2006.01) A61P 9 / 00(2006.01) A61P 3 / 06(2006.01) A61P 1 / 16(2006.01) A61P 9 / 10(2006.01) (54) Invention Title: Diaminocyclopentyl-substituted heteroaryl derivatives, their uses and preparation methods (57) Abstract: A diaminocyclopentyl-substituted heteroaryl derivative is provided, its uses and preparation methods are provided, particularly relating to a compound of formula (I), wherein the definitions of each substituent are given in the specification, and its preparation method, wherein the compound can be used as a PCSK9 inhibitor for the prevention and / or treatment of PCSK9-mediated diseases and conditions.CN 121443616 A 2026.01.30 CN 1 21 44 36 16 A.
